The Cooper Companies, Inc. (COO) Total Return CAGR:-4.24%(TTM)
Over the latest trailing 12-month period, The Cooper Companies, Inc. (COO)'s total return cagr is -4.24%. The comparable SPY value is +24.27%. Year-to-date total return is -17.18%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, The Cooper Companies, Inc.'s Total Return CAGR averages -8.63% over 3 years and -6.25% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of The Cooper Companies, Inc.'s investment performance.
COO Total Return CAGR Chart
The Cooper Companies, Inc. (COO)
COO Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
COO Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 5219.89 | 4323.16 | -896.73 | -17.18% | -17.18% |
| 2025 | 5854.87 | 5219.89 | -634.97 | -10.85% | -10.85% |
| 2024 | 6025.55 | 5854.87 | -170.68 | -2.83% | -2.83% |
| 2023 | 5264.25 | 6025.55 | +761.30 | +14.46% | +14.46% |
| 2022 | 6668.47 | 5264.25 | -1404.22 | -21.06% | -21.06% |
| 2021 | 5781.97 | 6668.47 | +886.49 | +15.33% | +15.33% |
| 2020 | 5111.98 | 5781.97 | +669.99 | +13.11% | +13.11% |
| 2019 | 4048.93 | 5111.98 | +1063.05 | +26.26% | +26.26% |
| 2018 | 3465.21 | 4048.93 | +583.72 | +16.85% | +16.85% |
| 2017 | 2781.18 | 3465.21 | +684.03 | +24.60% | +24.60% |
| 2016 | 2132.87 | 2781.18 | +648.31 | +30.40% | +30.40% |
| 2015 | 2575.05 | 2132.87 | -442.18 | -17.17% | -17.17% |
| 2014 | 1966.66 | 2575.05 | +608.38 | +30.93% | +30.93% |
| 2013 | 1467.86 | 1966.66 | +498.80 | +33.98% | +33.98% |
| 2012 | 1118.37 | 1467.86 | +349.49 | +31.25% | +31.25% |
| 2011 | 893.01 | 1118.37 | +225.36 | +25.24% | +25.24% |
| 2010 | 603.06 | 893.01 | +289.95 | +48.08% | +48.08% |
| 2009 | 258.76 | 603.06 | +344.31 | +133.06% | +133.06% |
| 2008 | 599.09 | 258.76 | -340.33 | -56.81% | -56.81% |
| 2007 | 700.95 | 599.09 | -101.87 | -14.53% | -14.53% |
| 2006 | 806.96 | 700.95 | -106.00 | -13.14% | -13.14% |
| 2005 | 1108.88 | 806.96 | -301.92 | -27.23% | -27.23% |
| 2004 | 739.37 | 1108.88 | +369.50 | +49.98% | +49.98% |
| 2003 | 392.30 | 739.37 | +347.07 | +88.47% | +88.47% |
| 2002 | 390.93 | 392.30 | +1.38 | +0.35% | +0.35% |
| 2001 | 310.83 | 390.93 | +80.10 | +25.77% | +25.77% |
| 2000 | 234.71 | 310.83 | +76.12 | +32.43% | +32.43% |
| 1999 | 160.87 | 234.71 | +73.84 | +45.90% | +45.90% |
| 1998 | 317.39 | 160.87 | -156.52 | -49.32% | -49.32% |
| 1997 | 134.16 | 317.39 | +183.23 | +136.57% | +136.57% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 4,323 | -3.0% | -2.6% |
| Q1 2026 | 4,456 | -14.9% | -16.4% |
| Q4 2025 | 5,235 | +21.7% | -10.6% |
| Q3 2025 | 4,302 | -3.1% | -38.8% |
| Q2 2025 | 4,438 | -16.7% | -20.2% |
| Q1 2025 | 5,331 | -9.0% | -17.8% |
| Q4 2024 | 5,855 | -16.7% | -1.5% |
| Q3 2024 | 7,027 | +26.4% | +34.2% |
| Q2 2024 | 5,560 | -14.3% | -6.4% |
| Q1 2024 | 6,486 | +9.1% | +9.1% |
| Q4 2023 | 5,945 | +13.5% | +13.7% |
| Q3 2023 | 5,236 | -11.8% | +24.7% |
| Q2 2023 | 5,939 | -0.1% | +15.8% |
| Q1 2023 | 5,944 | +13.7% | -9.4% |
| Q4 2022 | 5,228 | +24.5% | -17.0% |
| Q3 2022 | 4,200 | -18.1% | -38.2% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White